BioCentury | Feb 27, 2006
Tools & Techniques

Better ubiquitin screening

The ubiquitin proteasome pathway is involved in many cell processes, including apoptosis, immune response, cell cycle progression, gene expression regulation and DNA repair. But its complexity makes it difficult to build assays to gauge the...
BC Week In Review | Jan 22, 2001
Clinical News

Automated Structure Estimation and Refinement for NMR regulatory update

Structural received U.S. Patent No. 6,125,235 covering its ASTER-N technology, which generates 3-D structures of large proteins. The technology was developed by Moldyn Inc. (Cambridge, Mass.), which Structural acquired last month (see BioCentury, Dec. 11,...
Items per page:
1 - 2 of 2
BioCentury | Feb 27, 2006
Tools & Techniques

Better ubiquitin screening

The ubiquitin proteasome pathway is involved in many cell processes, including apoptosis, immune response, cell cycle progression, gene expression regulation and DNA repair. But its complexity makes it difficult to build assays to gauge the...
BC Week In Review | Jan 22, 2001
Clinical News

Automated Structure Estimation and Refinement for NMR regulatory update

Structural received U.S. Patent No. 6,125,235 covering its ASTER-N technology, which generates 3-D structures of large proteins. The technology was developed by Moldyn Inc. (Cambridge, Mass.), which Structural acquired last month (see BioCentury, Dec. 11,...
Items per page:
1 - 2 of 2